Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients

Stéphanie Bibert(University of Lausanne), Frédéric Lamoth(University of Lausanne), Thomas Brahier(University of Lausanne), Lauro Damonti(University Hospital of Bern), Nathalie Rufer(University of Lausanne), Jean‐Luc Pagani(University of Lausanne), Pierre–Yves Bochud(University of Lausanne), João Lourenço(SIB Swiss Institute of Bioinformatics), Oriol Manuel(University of Lausanne), Matthaios Papadimitriou‐Olivgeris(University Hospital of Lausanne), Jonathan Tschopp(University of Lausanne), Nicolas Guex(University of Lausanne), Fabio Candotti(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Robin Liechti(SIB Swiss Institute of Bioinformatics), Mathieu Quinodoz(University of Leicester), Lou Götz(SIB Swiss Institute of Bioinformatics), Mauro Delorenzi(SIB Swiss Institute of Bioinformatics), Cathy Voide(Hôpital du Valais), Noémie Boillat‐Blanco(University of Lausanne), Mauro Oddo(University Hospital of Lausanne), Véronique Erard(Réseau Fribourgeois de Santé Mentale), Olivier Hügli(University Hospital of Lausanne), Carlo Rivolta(University of Lausanne), Péter Vollenweider(University of Lausanne)
Frontiers in Immunology
May 31, 2021
Cited by 45


Related Papers